Scarica l'app Stockscreener
2.44
1.21%
-0.03
Dopo l'orario di chiusura:
2.50
0.06
+2.46%
Precedente Chiudi:
$2.47
Aprire:
$2.5
Volume 24 ore:
268.59K
Relative Volume:
0.71
Capitalizzazione di mercato:
$53.00M
Reddito:
-
Utile/perdita netta:
$-16.51M
Rapporto P/E:
-1.8037
EPS:
-1.3528
Flusso di cassa netto:
$-15.68M
1 W Prestazione:
-9.63%
1M Prestazione:
+5.40%
6M Prestazione:
-41.96%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.35
$2.50
Intervallo di 1 settimana:
$2.30
$2.74
Portata 52W:
$1.7901
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Nome
Medicus Pharma Ltd
Settore
Industria
Telefono
610-540-7515
Indirizzo
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Confronta MDCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.44 | 53.00M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
862.86 | 757.06B | 59.42B | 18.41B | -50.20M | 20.22 |
|
JNJ
Johnson Johnson
|
188.87 | 455.48B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
218.04 | 403.13B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
123.79 | 235.26B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
85.98 | 215.51B | 63.99B | 19.05B | 14.72B | 7.5596 |
Medicus Pharma Ltd Borsa (MDCX) Ultime notizie
What risks investors should watch in Medicus Pharma Ltd. Equity Warrant stockBear Alert & Low Drawdown Momentum Trade Ideas - newser.com
Why Medicus Pharma Ltd. (N460) stock could be top winnerTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Medicus Pharma Ltd. To Present at Brookline Capital Markets - Courier & Press
Technical signs of recovery in Medicus Pharma Ltd.2025 Breakouts & Breakdowns & Safe Entry Zone Identification - newser.com
Applying Elliott Wave Theory to Medicus Pharma Ltd. Equity WarrantJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com
Chart based exit strategy for Medicus Pharma Ltd. Equity WarrantDip Buying & Advanced Swing Trade Entry Alerts - newser.com
How Medicus Pharma Ltd. (N460) stock behaves under inflation pressureJuly 2025 Update & Fast Entry High Yield Tips - newser.com
How Medicus Pharma Ltd. (N460) stock reacts to monetary easingTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Medicus Pharma eyes compassionate use approval of Skinject for Gorlin SyndromeICYMI - Proactive financial news
Why Medicus Pharma Ltd. Equity Warrant stock is favored by pension funds2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock a safe buy before earningsJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com
What MACD and RSI say about Medicus Pharma Ltd.Weekly Stock Summary & Consistent Income Trade Recommendations - newser.com
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - The Holland Sentinel
Technical analysis overview for Medicus Pharma Ltd. Equity Warrant stockMarket Risk Analysis & AI Driven Price Predictions - newser.com
How resilient is Medicus Pharma Ltd. Equity Warrant stock in market downturns2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Real time breakdown of Medicus Pharma Ltd. stock performanceDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosMarket Trend Report & Community Verified Watchlist Alerts - newser.com
Medicus Pharma Ltd. stock trendline breakdown2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Medicus Pharma Ltd. Equity Warrant stock momentum explainedJuly 2025 Summary & Proven Capital Preservation Tips - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock supported by innovation pipelineAnalyst Downgrade & Free High Return Stock Watch Alerts - newser.com
Should you wait for a breakout in Medicus Pharma Ltd.July 2025 Outlook & Free Safe Capital Growth Stock Tips - newser.com
How Medicus Pharma Ltd. Equity Warrant stock benefits from global expansion2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Why Medicus Pharma Ltd. (N460) stock fits value portfolios2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com
Can Medicus Pharma Ltd. Equity Warrant stock resist market sell offsOptions Play & Verified Swing Trading Watchlist - newser.com
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome - Chambersburg Public Opinion
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The Holland Sentinel
Medicus Pharma Ltd’s Strategic Collaboration and Promising Phase 2 Results Justify Buy Rating - TipRanks
Medicus Pharma partners with Gorlin Syndrome Alliance to expand compassionate access to SKINJECT - Proactive financial news
Medicus Pharma Collaborates with Gorlin Syndrome Alliance for SKINJECT™ Access - MSN
Is Medicus Pharma Ltd. Equity Warrant stock reversal real or fake2025 Earnings Surprises & Daily Technical Stock Forecast Reports - newser.com
Can Medicus Pharma Ltd. stock deliver consistent earnings growthJuly 2025 Market Mood & Community Consensus Stock Picks - newser.com
What momentum indicators show for Medicus Pharma Ltd. stockJuly 2025 Market Mood & Low Drawdown Investment Strategies - newser.com
Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.71%
1.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):